Research programme: thyroid hormone agonists-dyslipidaemia - Karo Pharma
Alternative Names: KB 3495; KB 5359; STADs; TR STADLatest Information Update: 21 Dec 2016
At a glance
- Originator Karo Bio
- Class
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Lipid metabolism disorders
Most Recent Events
- 12 Feb 2008 Discontinued - Preclinical for Lipid metabolism disorders in Sweden (unspecified route)
- 04 Jul 2007 This programme is still in active development
- 14 Oct 2005 This programme is still in active development